Differential interactions of cholecystokinin and FLFQPQRF-NH2 with μ and δ opioid antinociception in the rat spinal cord
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Neuropeptides
- Vol. 16 (4) , 213-218
- https://doi.org/10.1016/0143-4179(90)90065-7
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Cholecystokinin and an evoked response in the dentate gyrusNeuropeptides, 1988
- Central administration of cholecystokinin potentiates evoked potential amplitude in the hippocampal dentate gyrusNeuropeptides, 1988
- Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1Life Sciences, 1986
- Peripheral and central origin of Phe-Met-Arg-Phe-amide immunoreactivity in rat spinal cordRegulatory Peptides, 1986
- Potentiation of morphine analgesia by the cholecystokinin antagonist proglumideBrain Research, 1985
- FMRFamide-like immunoreactivity in rat brain: Development of a radioimmunoassay and its application in studies of distribution and chromatographic propertiesBrain Research, 1983
- Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate AnalgesiaScience, 1983
- Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cordBrain Research, 1982
- The effects of C-terminal fragments of cholecystokinin on the firing of single neurones in the caudal trigeminal nucleus of the ratNeuropeptides, 1982
- Localization and opiate receptor binding of enkephalin, CCK and ACTH/β-endorphin in the rat central nervous systemPeptides, 1981